European Archives - Page 734 of 1225 - European Medical Journal

Continue
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
13 Mins
13 Oct 2020

Review of The Digital International Liver Congress (ILC) 2020

LONDON, UK, is considered to be one of the world’s most influential cities, with a significant impact on arts, commerce, and finance…
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
October 2020

EMJ Hepatology [Supplement 2] ILC Congress Review 2020

The International Liver Congress (ILC) took place digitally this year to ensure the dissemination of ground-breaking research could still take place…
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
2 Mins
13 Oct 2020

Diagnostic and Prognostic Role of Presepsin in Patients with Cirrhosis and Bacterial Infection

Bacterial infection (BI) is a common event in the natural history of cirrhosis, often requiring hospitalisation due to hepatic and extra-hepatic organ dysfunction..
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
1 Mins
13 Oct 2020

Fibrosis-4 Score for Assessment of Liver Fibrosis is Useful in General Practice

Early recognition of liver fibrosis will be a challenge that continues in the coming years and should be performed by general practitioners (GP)…
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
4 Mins
13 Oct 2020

COVID-19 and the Liver

IN THIS YEAR’S European Association for the Study of the Liver (EASL) Digital International Liver Congress (ILC) 2020, the session…
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
5 Mins
13 Oct 2020

Precision Medicine in NAFLD: Are We There Yet?

PRESENTING at an interactive session entitled ‘Precision medicine for the management of NAFLD – Are we there yet?’ at The Digital…
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
1 Mins
13 Oct 2020

FIB-4 and APRI Scores Revalidation in a Cohort Study of 69,106 Chronic Hepatitis C Patients

Assessment of liver fibrosis is vital for enabling therapeutic decisions and prognostic evaluation of chronic hepatitis…
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
1 Mins
13 Oct 2020

Progress in Hepatitis C Testing as Part of the Hepatitis C Elimination Programme in Georgia

In April 2015, the country of Georgia, with a high prevalence of hepatitis C virus (HCV) infection (5.4% of the adult population, approximately 150,000 persons), embarked on the world’s first national HCV Elimination programme…
3 Mins
13 Oct 2020

ILC Congress Interview: Prof Christian Trautwein

Prof Christian Trautwein | European Association for the Study of the Liver (EASL) Ethics Committee ChairpersonThe Department of Gastroenterology…
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
1 Mins
13 Oct 2020

Multivariant Surface Quasispecies in a Hepatitis B Virus Chronically Infected Individual with Concomitant and Continually Positive Surface Antigen and Anti-Hbs Biomarkers

Coexistence of hepatitis B virus (HBV) surface antigen (HBsAg) and antibodies (anti-HBs) can be found in 2.3–5.2% of chronic HBV (CHB) infected individuals…
We’ve noticed you’re accessing
from North/South America.